AAAAAA

   
Results: 1-25 | 26-50 | 51-74
Results: 1-25/74
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons
Authors: White, AR Guirguis, R Brazier, MW Jobling, MF Hill, AF Beyreuther, K Barrow, CJ Masters, CL Collins, SJ Cappai, R
Citation: Ar. White et al., Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons, NEUROBIOL D, 8(2), 2001, pp. 299-316
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
Authors: Cherny, RA Atwood, CS Xilinas, ME Gray, DN Jones, WD McLean, CA Barnham, KJ Volitakis, I Fraser, FW Kim, YS Huang, XD Goldstein, LE Moir, RD Lim, JT Beyreuther, K Zheng, H Tanzi, RE Masters, CL Bush, AI
Citation: Ra. Cherny et al., Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, NEURON, 30(3), 2001, pp. 665-676
Variable phenotype of Alzheimer's disease with spastic paraparesis
Authors: Smith, MJ Kwok, JBJ McLean, CA Kril, JJ Broe, GA Nicholson, GA Cappai, R Hallupp, M Cotton, RGH Masters, CL Schofield, PR Brooks, WS
Citation: Mj. Smith et al., Variable phenotype of Alzheimer's disease with spastic paraparesis, ANN NEUROL, 49(1), 2001, pp. 125-129
Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126
Authors: Stewart, LR White, AR Jobling, MF Needham, BE Maher, F Thyer, J Beyreuther, K Masters, CL Collins, SJ Cappai, R
Citation: Lr. Stewart et al., Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126, J NEUROSC R, 65(6), 2001, pp. 565-572
Clioquinol's return: Cautions from Japan - Response
Authors: Bush, AI Masters, CL
Citation: Ai. Bush et Cl. Masters, Clioquinol's return: Cautions from Japan - Response, SCIENCE, 292(5525), 2001, pp. 2251-2252
Memory decline in healthy older people - Implications for identifying mildcognitive impairment
Authors: Collie, A Maruff, P Shafiq-Antonacci, R Smith, M Hallup, M Schofield, PR Masters, CL Currie, J
Citation: A. Collie et al., Memory decline in healthy older people - Implications for identifying mildcognitive impairment, NEUROLOGY, 56(11), 2001, pp. 1533-1538
The emerging European epidemic of variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: lessons for Australia
Authors: Masters, CL
Citation: Cl. Masters, The emerging European epidemic of variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: lessons for Australia, MED J AUST, 174(4), 2001, pp. 160-161
The Worster-Drought syndrome and other syndromes of dementia with spastic paraparesis: The paradox of molecular pathology
Authors: Masters, CL Beyreuther, K
Citation: Cl. Masters et K. Beyreuther, The Worster-Drought syndrome and other syndromes of dementia with spastic paraparesis: The paradox of molecular pathology, J NE EXP NE, 60(4), 2001, pp. 317-319
Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways
Authors: White, AR Huang, XD Jobling, MF Barrow, CJ Beyreuther, K Masters, CL Bush, AI Cappai, R
Citation: Ar. White et al., Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways, J NEUROCHEM, 76(5), 2001, pp. 1509-1520
The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease
Authors: Campbell, BCV McLean, CA Culvenor, JG Gai, WP Blumbergs, PC Jakala, P Beyreuther, K Masters, CL Li, QX
Citation: Bcv. Campbell et al., The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease, J NEUROCHEM, 76(1), 2001, pp. 87-96
Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma-secretase inhibitor - Implications for presenilin biology
Authors: Beher, D Wrigley, JDJ Nadin, A Evin, G Masters, CL Harrison, T Castro, JL Shearman, MS
Citation: D. Beher et al., Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma-secretase inhibitor - Implications for presenilin biology, J BIOL CHEM, 276(48), 2001, pp. 45394-45402
Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits
Authors: Curtain, CC Ali, F Volitakis, I Cherny, RA Norton, RS Beyreuther, K Barrow, CJ Masters, CL Bush, AI Barnham, KJ
Citation: Cc. Curtain et al., Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J BIOL CHEM, 276(23), 2001, pp. 20466-20473
The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase
Authors: Nunan, J Shearman, MS Checler, F Cappai, R Evin, G Beyreuther, K Masters, CL Small, DH
Citation: J. Nunan et al., The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase, EUR J BIOCH, 268(20), 2001, pp. 5329-5336
Interaction of linear homologous DNA duplexes via Holliday junction formation
Authors: Yakubovskaya, MG Neschastnova, AA Humphrey, KE Babon, JJ Popenko, VI Smith, MJ Lambrinakos, A Lipatova, ZV Dobrovolskaia, MA Cappai, R Masters, CL Belitsky, GA Cotton, RG
Citation: Mg. Yakubovskaya et al., Interaction of linear homologous DNA duplexes via Holliday junction formation, EUR J BIOCH, 268(1), 2001, pp. 7-14
Identification of structural variations in the carboxyl terminus of Alzheimer's disease-associated beta A4[1-42] amyloid using a monoclonal antibody
Authors: Jayasena, ULHR Gribble, SK McKenzie, A Beyreuther, K Masters, CL Underwood, JR
Citation: Ulhr. Jayasena et al., Identification of structural variations in the carboxyl terminus of Alzheimer's disease-associated beta A4[1-42] amyloid using a monoclonal antibody, CLIN EXP IM, 124(2), 2001, pp. 297-305
Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease
Authors: Evin, G Sharples, RA Weidemann, A Reinhard, FBM Carbone, V Culvenor, JG Holsinger, RMD Sernee, MF Beyreuther, K Masters, CL
Citation: G. Evin et al., Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease, BIOCHEM, 40(28), 2001, pp. 8359-8368
Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126
Authors: Jobling, MF Huang, XD Stewart, LR Barnham, KJ Curtain, C Volitakis, I Perugini, M White, AR Cherny, RA Masters, CL Barrow, CJ Collins, SJ Bush, AI Cappai, R
Citation: Mf. Jobling et al., Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126, BIOCHEM, 40(27), 2001, pp. 8073-8084
Statistical evaluation of voltages in distribution systems with embedded wind generation
Authors: Masters, CL Mutale, J Strbac, G Curcic, S Jenkins, N
Citation: Cl. Masters et al., Statistical evaluation of voltages in distribution systems with embedded wind generation, IEE P-GEN T, 147(4), 2000, pp. 207-212
Correct heteroduplex formation for mutation detection analysis
Authors: Smith, MJ Humphrey, KE Cappai, R Beyreuther, K Masters, CL Cotton, RGH
Citation: Mj. Smith et al., Correct heteroduplex formation for mutation detection analysis, MOL DIAGN, 5(1), 2000, pp. 67-73
Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease
Authors: Cherny, RA Barnham, KJ Lynch, T Volitakis, I Li, QX McLean, CA Multhaup, G Beyreuher, K Tanzi, RE Masters, CL Bush, AI
Citation: Ra. Cherny et al., Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease, J STRUCT B, 130(2-3), 2000, pp. 209-216
Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies
Authors: Campbell, BCV Li, QX Culvenor, JG Jakala, P Cappai, R Beyreuther, K Masters, CL McLean, CA
Citation: Bcv. Campbell et al., Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies, NEUROBIOL D, 7(3), 2000, pp. 192-200
Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease
Authors: Collins, S Boyd, A Fletcher, A Gonzales, MF McLean, CA Masters, CL
Citation: S. Collins et al., Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease, J CL NEUROS, 7(3), 2000, pp. 195-202
Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid
Authors: Collins, S Boyd, A Fletcher, A Gonzales, M McLean, CA Byron, K Masters, CL
Citation: S. Collins et al., Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid, J CL NEUROS, 7(3), 2000, pp. 203-208
Presenilin I expression in yeast lowers secretion of the amyloid precursorprotein
Authors: Evin, G Le Brocque, D Culvenor, JG Galatis, D Weidemann, A Beyreuther, K Masters, CL Cappai, R
Citation: G. Evin et al., Presenilin I expression in yeast lowers secretion of the amyloid precursorprotein, NEUROREPORT, 11(2), 2000, pp. 405-408
Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta 42(43) peptide levels and induces apoptosis
Authors: Kwok, JBJ Li, QX Hallupp, M Whyte, S Ames, D Beyreuther, K Masters, CL Schofield, PR
Citation: Jbj. Kwok et al., Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta 42(43) peptide levels and induces apoptosis, ANN NEUROL, 47(2), 2000, pp. 249-253
Risultati: 1-25 | 26-50 | 51-74